SUFFOLK, United Kingdom--(BUSINESS WIRE)--A recent academic paper published in the journal Organic Process Research and Development by the Group of Prof Steven V. Ley, Department of Chemistry, University of Cambridge (UK) outlines a breakthrough on the manufacture of breast cancer drug Tamoxifen involving flow chemistry technology developed by UK specialist chemical engineering firm Vapourtec. A prominent feature in the success of the research carried out, profiled in the article “Continuous flow-processing of organometallic reagents using an advanced peristaltic pumping system and the telescoped flow synthesis of (E/Z)-tamoxifen”, was the use of Vapourtec’s E-Series flow chemistry system that enables the processing of organometallic reagents.
Help employers find you! Check out all the jobs and post your resume.
